INCR Intercure delivers 287 percent Q2 2023 EPS beat even as shares dip 048 percent in todays trading CAC Camden Natl posts nearexpected Q4 2025 EPS shares slip 04 on mild investor caution Is Cango CANG stock showing downside risk Q4 2025 EPS Misses Views Is Vera Therapeutics VERA stock slowing down Vera Therapeutics reports wider loss on 63 EPS miss EW SSP Competitive Edge EW delivers 139 percent EPS beat topping analyst estimates